Last reviewed · How we verify
NCT03941678
Creatine Supplementation During Resistance Training for People Recovering From Stroke
NA trial testing Creatine monohydrate in Stroke in 8 participants. Completed in 30 May 2020.
30 December 2019
Quick facts
| Lead sponsor | University of Saskatchewan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 8 |
| Start date | 30 May 2019 |
| Primary completion | 30 December 2019 |
| Estimated completion | 30 May 2020 |
| Sites | 2 locations across Canada |
Drugs / interventions tested
- Creatine monohydrate — full drug profile →
- Placebo
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
University of Saskatchewan
Who can join
18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Creatine monohydrate is important for sustaining phosphocreatine stores in tissues such as muscle and brain. Phosphocreatine is an important source of energy in these tissues. Supplementation with creatine monohydrate is effective in healthy and clinical populations for improving muscle and brain function. The purpose of our study is to determined whether creatine supplementation is effective during resistance training for improving muscle and brain function in people recovering from stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Creatine Supplementation and Progressive Resistance Training in Stroke Survivors.
Butchart S, Candow DG, Forbes SC, Mang CS, et al · · 2022 · cited 6× · PMID 35992184 · DOI 10.70252/ekhj1489
Verify or expand the search:
- PubMed search for NCT03941678
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Creatine monohydrate
Trials testing the same drug.
- NCT07310043 — Creatine and Perioperative Brain Health · NA · not yet recruiting
- NCT06992414 — Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19 · NA · not yet recruiting
- NCT06576466 — Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke · NA · recruiting
- NCT06438887 — Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults · NA · recruiting
- NCT04395183 — 5-HTP and Creatine for Depression · Phase 2 · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other University of Saskatchewan trials
Trials by the same sponsor.
- NCT07433686 — Saskatoon Berry Juice for Muscle Recovery · NA · not yet recruiting
- NCT07489469 — Effectiveness of an AI Scribe Compared to Routine Templates for Clinical Documentation in Orthopedic Consultations · NA · completed
- NCT06946316 — Dairy vs Plant-based Beverages for Improving Bone Health During Exercise · NA · recruiting
- NCT04276857 — Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer · NA · recruiting
- NCT03401294 — Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03941678 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Saskatchewan
- Last refreshed: 11 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03941678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing